Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Predictive ability of intracerebral hemorrhage scales in minimally invasive hematoma evaluation
Cerebrovascular Disease and Interventional Neurology
P12 - Poster Session 12 (12:00 PM-1:00 PM)
4-017
To compare the mortality rate of patients with intracerebral hemorrhage (ICH) who received a novel neuroendoscopic intervention called the Stereotactic Intra-Cerebral Hemorrhage Underwater Blood Aspiration (SCUBA) technique for ICH evacuation versus the mortality rates of patients with ICH predicted by various ICH prediction scores. 
Spontaneous ICH is a neurological emergency with a high mortality rate. Our center developed the SCUBA technique for ICH evacuation. Over the past couple decades, numerous scores were created in the attempt to predict mortality rates of patients with ICH. We wanted to compare the mortality rates of patients with ICH who received the SCUBA intervention against the predicted mortality rates of various ICH prediction scores.
We searched the literature for ICH prediction scores. Eight scores were selected based on their relevance, and whether or not data for the variables they examined were available in our electronic medical records. Then we performed chart review on 100 patients who received the SCUBA intervention to collect data on the variables measured by the prediction tools. Then, scores based on the prediction tools and mortalities rates were calculated. The mortality rates of our patient cohort were compared against the predicted mortality rates of the various prediction scores.
Overall, patients who received the SCUBA intervention had significantly lower mortality rates than what is predicted by all eight of the prediction scores. Mortality rates of patients who received SCUBA intervention versus predicted mortality rates are as follows, 1) oICH 9.0% versus 44.7%, 2) SwICH 4.5% versus 14.0%, 3) ICH FOUR 3.5% versus 28.8%, 4) 25.0% versus 30.1%, 5) MICH 9.0% versus 21.8%, 6) New ICH 3.5% versus 21.8%, 7) ICH-GS 9.0% versus 57.0%, and 8) sICH 4.4% versus 13.7%.
SCUBA is a robust technique for ICH evacuation that results in lower mortality rates than is predicted by eight ICH prediction scores.
Authors/Disclosures
Terrence Tian, MD
PRESENTER
No disclosure on file
No disclosure on file
Kaitlin Reilly-Kit, MD (Hackensack University Medical Center) Dr. Reilly-Kit has nothing to disclose.
Alexandra S. Reynolds, MD Dr. Reynolds has nothing to disclose.
No disclosure on file
Neha Dangayach, MD, FÂé¶¹´«Ã½Ó³»­ (Icahn School of Medicine At Mount Sinai and Mount Sinai Hospital) Dr. Dangayach has nothing to disclose.
Christopher P. Kellner, MD (Mount Sinai Health System) Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. Dr. Kellner has stock in Radical. Dr. Kellner has stock in Reach Neuro. Dr. Kellner has stock in Aurenar. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.
John Liang, MD (Mount Sinai Health System) Dr. Liang has nothing to disclose.